Central University of Ecuador Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2004
NCT00300937
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Biomedical Center - Central University of Ecuador | Central University, Ecuador | Teran, Enrique, MD, PhD

Active Ingredients

Drugs in Phase 3 Trials (1)

ubiquinone (1 trial)

Drugs in Other Trials (1)

multivitamins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pre-Eclampsia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2